Arix Bioscience

Arix Bioscience, a UK-based research and development services company, reported total market-based Scope 1 and 2 emissions of approximately 12,570 kg CO2e in 2022.

In 2022, the company's Scope 1 emissions were 3,680 kg CO2e, and Scope 2 (market-based) emissions were 8,890 kg CO2e. Scope 3 emissions were reported as 5,210 kg CO2e. This follows a trend from 2021, where Scope 1 emissions were 4,860 kg CO2e, Scope 2 (market-based) emissions were 7,800 kg CO2e, and Scope 3 emissions were 2,900 kg CO2e. In 2020, Scope 1 emissions were 5,020 kg CO2e and Scope 2 (market-based) emissions were 5,110 kg CO2e; Scope 3 data was not available for 2020. The earliest available data from 2019 showed Scope 1 emissions of 11,500 kg CO2e and Scope 2 (market-based) emissions of 5,600 kg CO2e.

Arix Bioscience has set a long-term net-zero target to reduce more than 90% of its emissions across all scopes by 2050, operating as a fully Net-Zero business. Additionally, the company aims for a 40% reduction in carbon emissions by 2025 compared to a 2019 baseline, normalised to occupied areas.